Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

Health, Fitness & Food

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.)

Products You May Like

Articles You May Like

Therabody’s Compression Boots Are a Total Game Changer For Recovery — Here’s Why
How Trump’s win could change your health care
I Tried the $7,500 a Month Gym. Is It Worth It?
Smoked Salmon Cucumber Bites
These Black F1 Fans Are Changing the Narrative Around the Sport

Leave a Reply

Your email address will not be published. Required fields are marked *